Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
327.20    -8.20 (-2.44%)
Bid:
327.00
Ask:
328.40
Spread: 1.40 (0.428%)
Market Cap: £716.79m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

AGM Statement of Result

16 May 2017 12:06

RNS Number : 3042F
Burford Capital
16 May 2017
 

 

16 May 2017

 

BURFORD CAPITAL LIMITED

 

RESULT OF AGM

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), a leading global finance firm focused on law, is pleased to announce that all resolutions proposed at its Annual General Meeting today were approved by shareholders.

 

Among other matters, shareholders approved the dividend payment of 6.48¢ per share. That dividend will be payable on 16 June 2017 to shareholders on the register as at the close of business on Friday 26 May 2017.

 

The votes received are detailed below:

 

Ordinary Resolutions

Total votes for

Total votes against

Total votes withheld

1. To receive the accounts for the year ended 31 December 2016 and the directors' and auditors' reports thereon

163,456,175

253,602

0

2. To declare a final dividend of 6.48¢ (United States cents) per ordinary share

163,709,640

137

0

3. To re-appoint Sir Peter Middleton as a director

163,078,135

629,580

2,063

4. To re-appoint Charles Parkinson as a director

163,078,272

629,443

2,063

5. To re-appoint Ernst & Young LLP as the Company's auditors

163,176,819

531,821

1,137

6. To authorise the directors to agree the auditors' remuneration

163,431,558

278,219

0

7. To authorise the directors to allot up to 69,412,660 shares and up to 138,825,319 by way of a rights issue

162,837,329

872,311

137

8. To authorise the Company to purchase its own shares up to a specified amount

163,706,621

3,156

0

Special Resolutions

9. To authorise the directors to allot shares for cash without making a pre-emptive offer to shareholders (subject to the limitation set out in the resolution)

163,672,184

17,593

20,000

 

 

 

For further information, please contact:

 

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

Nicholas Harland

Liberum Capital Limited-  Joint Broker

+44 (0)20 3100 2222

Richard Crawley

Jamie Richards

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

Andrew Holloway

Neustria Partners - Financial Communications for Burford Capital

+44 (0)20 3021 2580

Robert Bailhache [robert.bailhache@neustriapartners.com]

Charles Gorman [charles.gorman@neustriapartners.com]

 

Nick Henderson [nick.henderson@neustriapartners.com]

 

 

 

 

 

About Burford Capital

 

Burford Capital is a leading global finance firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London and Chicago.

 

For more information about Burford, visit www.burfordcapital.com

 

 

This release does not constitute an offer of any Burford fund.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGGGUPUAUPMGGQ
Date   Source Headline
29th May 20262:00 pmRNSSterling FX Rate for 2025 Final Dividend
21st May 202612:00 pmRNSNotice of Retail Shareholder Audio Webcast
14th May 202612:00 pmRNSResult of AGM
8th May 202612:00 pmRNS1Q26 Financial Results
5th May 202612:00 pmRNSNotice of 1Q26 Results & Results Call Details
7th Apr 20267:00 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSDirector/PDMR Shareholding & Issue of Equity
30th Mar 20267:00 amRNSBurford Capital Further Statement on YPF
30th Mar 20267:00 amRNSBurford Capital Statement Re YPF Appeal Decision
27th Mar 20263:32 pmRNSBurford Capital Statement re YPF Matter
17th Mar 202612:00 pmRNSCompletion of Share Repurchase Program
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
26th Feb 20261:00 pmRNSAnnual Results for Year Ended December 31, 2025
10th Feb 20261:00 pmRNSNotice of 2025 Results & Results Call Details
27th Jan 20261:30 pmRNSPricing of Early Redemption of Bonds Due 2026
15th Jan 20263:41 pmRNSNotice of Early Redemption of Bonds Due 2026
15th Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSPricing and Upsizing of Senior Notes Offering
12th Jan 20262:01 pmRNSPrivate Offering of Senior Notes
5th Jan 20261:00 pmRNSIssue of New Shares in Connection with LTIP
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
4th Dec 20251:00 pmRNSDirector/PDMR Shareholding
7th Nov 20251:00 pmRNSSterling Conversion Rate for 2025 Interim Dividend
6th Nov 20257:00 amRNSHolding(s) in Company
5th Nov 20251:00 pmRNSAppointment of Joint Corporate Broker
5th Nov 20251:00 pmRNS3Q25 and YTD25 Financial Results
29th Oct 20257:00 amRNSHolding(s) in Company
24th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20251:00 pmRNSNotice of 3Q25 Results & Results Call Details
22nd Oct 20251:00 pmRNSYPF Matter Update
10th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding & New Share Issuance
1st Oct 20252:00 pmRNSHolding(s) in Company
29th Sep 20251:00 pmRNSInterim Dividend Declaration
29th Sep 20257:00 amRNSHolding(s) in Company
23rd Sep 20259:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSDirector/PDMR Shareholding
7th Aug 20251:00 pmRNS2Q25 and YTD25 Financial Results
24th Jul 202512:00 pmRNSNotice of 2Q25 Results & Results Call Details
14th Jul 202512:00 pmRNSClosing of Private Offering of Senior Notes
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
8th Jul 20255:21 pmRNSPricing and Upsizing of Senior Notes Offering
7th Jul 202512:57 pmRNSPrivate Offering of Senior Notes
3rd Jul 202511:00 amRNSIssue of New Shares in Connection With LTIP
2nd Jul 20255:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.